1,1,1,3,3-Pentafluoropropane (HFC 245fa) is a volatile, low boiling liquid. It was inactive in a reverse mutation (Ames) assay using five strains of Salmonella typhimurium and one strain of Escherichia coli. It was also inactive in an in vivo mouse micronucleus assay with exposures of 101,000 ppm. In a chromosome aberration study with human lymphocytes, some activity was seen when cell cultures were exposed to atmospheres of 30% v/v or higher for 24 h without metabolic activation. No activity was seen in assays using less than 30% v/v or exposure times of less than 24 h. No activity was seen in the presence of metabolic activation even with exposures of 70%. It was not toxic by the dermal route. There was no mortality or significant signs of toxicity when rats and mice were given 4-h exposures to levels of 203,000 ppm or 101,000 ppm of HFC 245fa, respectively. In a cardiac sensitization study with dogs involving intravenous administration of epinephrine, the no observed effect level (NOEL) was 34,000 ppm and the threshold for a response was 44,000 ppm. In a rat inhalation, developmental toxicity study, a slight reduction in pup weight was seen at 50,000 ppm, but not at 10,000 ppm. There were no developmental effects at any level. A series of three inhalation toxicity studies were conducted. All involved daily 6-h exposures up to 50,000 ppm. The first study involved 14 consecutive snout-only exposures. There were no treatment-related effects on body weight, survival, or histologic parameters. BUN, GPT, and GOT levels frequently were elevated compared to controls , whereas cholesterol levels tended to be lower. The second study involved 28 consecutive whole-body exposures. Again, there were no treatment related effects on body weight, survival, or histological parameters. Urine volume was increased. Increases were also seen in several red blood cell parameters. These may be related to partial dehydration. Increases were seen in BUN levels and alkaline phosphatase (AP), GPT, GOT and CPK activities, primarily in rats exposed at 10,000 and 50,000 ppm. Urinary fluoride levels were also elevated in an exposure-related pattern. In the third study, whole-body exposures were conducted 5 days per week for 13 weeks. There were no treatment-related effects on survival, clinical observations, body weight gain, or food consumption. Urine volumes were increased, urinary fluoride levels were elevated, and increases were seen in red blood cell counts, and related parameters and increases were seen in AP, GOT, GPT and CPK activities. These effects were seen in the 10,000 and 50,000 ppm exposure level groups.
Following the publication by Molina and Roland (1974) which suggested that the chlorofluorocarbons (CFCs) could be transported to the stratosphere, releasing chlorine that could catalylitically break down ozone, research was initiated to find suitable replacements for these essential substances. This research was intensified with the ratification of the Montreal Protocol and its subsequent amendments, which mandate a phaseout of the CFCs (UNEP, 1991). The CFCs have been used in many applications such as solvents in precision cleaning, propellants for personal care and medicinal products, refrigerants, and foam-blowing agents. One reason for their popularity is their low toxicity. As potential replacements, molecules with hydrogen atoms are known to have shorter environmental half-lives than fully halogenated structures. Also, since ozone destruction is catalyzed by bromine and chlorine, but not fluorine, hydrofluorocarbons offer the advantage of a zero ozone depletion potential. Finally, it is important that the potential replacements have low toxicity.
Hydrofluorocarbons such as 1,1,1,2-tetrafluoroethane (HFC 134a) and penta-fluoroethane (HFC 125) have low toxicity (Collins et al., 1995; Kawano et al., 1995) . Neither showed remarkable toxicity in exposure studies lasting up to 3 months. 1,1,1,3,3-pentafluoropropane (HFC 245fa) is a higher boiling hydrofluorocarbon. It is under consideration for applications such as foam blowing, refrigeration, and precision cleaning. Recently the toxicology profile of this substance was evaluated in a series of studies looking at acute, subacute, subchronic, and developmental end points. The results of these studies are described in this paper.
MATERIALS AND METHODS

Test Material
1,1,1,3,3-Pentafluoropropane (HFC 245fa), CAS No. 460 -73-1 is a colorless, nonflammable liquid with a boiling point of 15°C. It was supplied as a liquified gas in cylinders from AlliedSignal Inc., Buffalo, NY at a minimum purity of 99.8%. All batches were analyzed by gas chromatography-mass spectroscopy (gc-ms) prior to use.
Analytical Determination of HFC 245fa in Air
For all rodent inhalation toxicity studies, calibration standards were prepared by injecting known amounts of HFC 245fa into a known volume of air in a Tedlar (SKC Inc., Eighty-Four, PA) gas sampling bag. Samples were withdrawn using gas tight Hamilton syringes (Fortuna PE/PP, W Graf GmbH & Co., Werthein, Germany) and a standard curve was generated on a gas chromatograph (gc).
Exposure levels in the inhalation chambers were monitored by withdrawing samples on at least hourly intervals using a gas tight syringe. The sample was analyzed by gc and compared to the standard curve.
The gas chromatograph used for this analysis was a Hewlett Packard 5890 (Hewlett Packard, Wilmington, DE) with a heated valve and split injection system. It was fitted with a GS-Q, 5 m ϫ 0.53 mm id stainless steel capillary column and a flame ionization detector. Chamber exposure levels were calculated using a Thermo Separation Products PC 1000 software integrator (Thermosystems Products, Fremont, CA).
For in vitro studies, the concentration of HFC 245fa was determined in the head space above the culture medium before and after exposure. As described for the in vivo studies, samples were removed from the exposure system using a gas tight syringe, analyzed by gas chromatography, and the concentration determined by reference to the standard curve. The gc instrument, column, detector, and conditions varied depending on equipment availability.
Genetic Assays
All in vitro studies were conducted using an apparatus described by HodsonWalker et. al. (1993) . The bacterial assays were performed in a closed stainless steel exposure vessel. All in vitro studies were conducted in the presence and absence of metabolic activation.
Reverse Mutation Assay
The reverse mutation assay was conducted according to the procedure previously described Maron and Ames, 1983) . Five strains of Salmonella typhimurium, TA 98, TA 1538, TA 100, TA 1535, and TA 1537 as well as Escherichia coli WP2 uvrA were employed. The plates were exposed to concentrations of HFC 245fa from 1.0% v/v to 100% v/v.
Chromosomal Aberrations in Cultured Human Lymphocytes
The effects of HFC 245fa on chromosomal structure were investigated in human lymphocytes obtained from healthy, nonsmoking male volunteers not currently taking any medication. This procedure has previously been described . For studies without metabolic activation, with a 6-h exposure time, atmospheric exposure levels from 40 to 70% v/v were used; for studies using a 24-h exposure time, atmospheric exposure levels of 10 -40% were used. For studies with metabolic activation (S-9), a 3-h exposure time was used with test atmosphere of 30 -70%.
Bone Marrow Micronucleus
The potential of HFC 245fa to cause micronuclei formation was evaluated using male and female CD-1 mice (Charles River Ltd., Margate, Kent, England). The animals weighed about 18 -22 grams and were 4 -5 weeks of age. The procedure has previously been described . A single group of 10 mice was exposed to a test atmosphere of 101,300 ppm v/v for 4 h; a second group of 10 mice was exposed to air for the same period. A positive control group of five mice was given an injection of 30 mg/kg of chlorambucil. Five mice from each group were killed 24 h after the start of the treatment; a second group of five mice from the HFC 245fa and air exposed populations were killed 48 h after the start of treatment.
Acute Dermal Toxicity
The acute percutaneous toxicity of HFC 245fa was evaluated in the rabbit using OECD Guideline, Section 4, Sub-Section 402. Briefly, a single application of 2 ml/kg of test substance was applied to the backs of five male and five female New Zealand white rabbits. It was covered with an occlusive dressing for 24 h. The animals were then observed for 14 days and sacrificed.
Acute Inhalation Toxicity
Mice. Male and female adult CD-1 mice (Charles River Ltd., Margate, Kent, England), 4 weeks of age with a weight range of 19 -22 g were used for this study. During nonexposure periods, the animals were housed five per cage separated by sex. The cages were polycarbonate with stainless steel lids. Temperature was maintained between 18 and 25°C and RH from 40 to 70%. The animal housing room was on a 12-h light/dark cycle. They were given free access to food (RM1, Special Diet Services Ltd., Witham, Essex, England) and tap water. The study population consisted of one control and one treatment group each with five male and five female mice.
The exposure chamber consisted of a 30-cm diameter aluminum alloy cylinder with an internal volume of approximately 36 l, with ports to permit snout-only exposure of up to 20 animals (ADG Instruments Ltd., Codicote, Hitchin, Hertfordshire, England). A closed loop recirculating test atmosphere exposure system was used. The test material was dispensed directly into this system from gas sampling bags filled with pure HFC 245fa. A diaphragm pump (Charles Austin, Model No. B100 SEC, Byfleet, Weybridge, Surrey, England) was used to circulate the atmosphere at a constant rate of approximately 10 l/min. Each mouse was placed in an individual polymethyl methacrylate restraining tube so that only the snout protruded. The tubes were attached to the exposure unit only after gc analysis confirmed that the target concentrations had been achieved. The exposures lasted for 4 h. The concentration of test substance was measured by gc at half-hourly intervals. Humidity, temperature and oxygen levels were continuously monitored. Excess water and CO 2 were removed using Zeolite molecular sieves of types 3A and 4A. Oxygen and water were added if needed.
The animals were observed immediately before exposure, 15 and 30 min into the exposure, at 30-min intervals for the remainder of the exposure and for 2 h postexposure. For the next 14 days, they were observed twice daily. Each mouse was weighed daily from receipt until sacrifice. At sacrifice, all mice were subjected to necropsy and all major organs were examined. Lungs, liver, and kidneys were weighed.
Rats. Three exposures were conducted, one using snout-only exposure and two using whole body exposure. Male and female Sprague-Dawley rats were obtained from Charles River (UK). Rats were about 8 weeks of age on receipt. They were divided into groups of five males and five females each. During nonexposure periods they were housed five per cage in stainless steel and stainless steel mesh cages in a temperature (18 -24°C) and humidity (40 -70%) controlled room using a 12-h light/dark cycle.
Whole-body exposures were conducted in perspex chambers with an internal volume of 70 l using a flow rate of 15 l/min. Animals were caged individually in the chamber. The snout-only exposure was conducted using an exposure chamber with an internal volume of 5 liters and a flow rate of 12 ll/min. The test substance was metered directly from the cylinder using a flow regulator into the oxygen-enriched (higher exposure levels only) chamber air supply. The exposures lasted 4 h.
The exposure concentrations were measured using a Wilks Miran 1A-CVF infra red spectrophotometer. Exposure levels were determined by reference to a standard curve generated by injecting known volumes of HFC 245fa into a standard volume cell. Chamber oxygen levels (21%) were measured using a Sybron Taylor (OA 250) oxygen meter. Temperature (23-25°C) and humidity were also measured.
Rats were observed during the exposures and daily during the 14-day postexposure observation period. Body weights were measured daily from the date of receipt until sacrifice. Food and water consumption were measured for each group of five rats also on a daily basis. All rats were sacrificed at the end of the 14-day postexposure observation period and subjected to a necropsy examination of all major organs. Lung weights were measured and lung/body weight ratios were calculated.
Cardiac Sensitization
The potential for HFC 245fa to induce cardiac sensitization was determined in beagle dogs (Interfauna UK, Ltd.) using methods and protocols modified from Reinhardt et al. (1971) . This end point is evaluated by first determining the threshold dose of intravenous epinephrine that will elicit a mild disturbance to the EKG (for example, 1 or 2 unifocal ectopic beats in the test animal). The animal is then given an exposure to pentafluoropropane. After 5 min, the animal is given a second injection of epinephrine at the threshold dose. If the combination of the exposure plus the epinephrine results in a marked disturbance to the EKG, for example, multifocal ectopic activity or ventricular fibrillation, the test material is considered to be a cardiac sensitizer at that exposure level. Subsequent exposures are conducted at lower levels, if a positive response is seen. If no response is seen, or only a few animals respond out of the total, exposures are also conducted at higher levels. The study involved a 10-min exposure to HFC 245fa (control or 34,000 -73,000 ppm) with intravenous injections of epinephrine prior to the exposure and at 5 min into the exposure (challenge). EKGs were monitored continuously during the exposure. In this manner, each dog served as its own control. All dogs were housed individually in runs. The six dogs preselected for this study were trained over a period of weeks to accept the procedure prior to actual treatment.
Developmental Toxicity Studies
Initially a range-finding study was conducted using five groups of 12 time-mated, specific pathogen-free rats (Crl:CD BR VAF/Plus; Charles River UK, Margate, Kent, UK). They were exposed to levels of 0 (control), 500, 2000, 10,000, and 50,000 ppm. As there were no obvious treatment-related effects on the litters or litter parameters, the main study was initiated at the same exposure levels. This study consisted of five groups of 25 time-mated rats (Crl:CD BR VAF/Plus). The procedures followed and evaluation criteria have been described elsewhere .
Repeat Administration Inhalation Toxicity Studies
Three inhalation toxicity studies were conducted with HFC 245fa. All used Charles River Sprague-Dawley CD rats (Charles River Ltd., Manston Road, Margate, Kent, England) obtained at approximately 6 weeks of age. The animals were housed in temperature and humidity controlled rooms with a 12-h light/dark cycle and fed SDS Rat and Mouse No. 1 SQC modified maintenance diet (Special Diet Services, Witham, Essex, UK) ad libitum during nonexposure periods. Tap water was also supplied ad libitum during nonexposure periods.
14-Day Study
In this study, four groups of five male and five female rats were exposed to vapors of HFC 245fa, snout only, 6 h/day for 14 consecutive days. The exposure levels used were 0 (control), 5000, 15,000 and 50,000 ppm. The exposure chamber design was similar to that previously described for the mouse acute inhalation study except that it had a diameter of 28 cm, an internal volume of 47 liters, and was designed to accept polycarbonate rat restraining tubes. The tubes were attached to the chambers by means of push-fit O-ring seals locked in the exposure ports of the animal exposure sections.
The liquid test substance was transferred from the bulk storage cylinder to a stainless steel pressure vessel held in water at 21 Ϯ 1°C. The vapor produced in the headspace above this vessel was allowed to pass under its own pressure to each of the exposure chambers. The final concentration in each chamber was controlled by an in-line needle valve rotameter. The HFC 245fa vapor was blended with the exposure system intake air. The exposure levels were monitored on at least hourly intervals using the gc method described above. Animals were examined daily and body weights were measured weekly. On the day prior to the final exposure, blood samples were collected for clinical evaluation. The parameters evaluated include creatinine phosphokinase (CPK), triglycerides, glucose, total protein, albumin, globulin (calculated), urea nitrogen, creatinine, alkaline phosphatase, glutamic-pyruvic transaminase (GPT), glutamic-oxaloacetic transaminase, total bilirubin, sodium, potassium, calcium, inorganic phosphorous, chloride and cholesterol. In addition, liver peroxisome activity was measured using the method of Angermuller and Fahimi (1981) . Organ weights were determined for the lungs, liver, kidneys, and epididymides with the testes. In addition to gross necropsy examination of all major organs, light microscopic examination was performed on 4-m thick sections, stained with haematoxylin and eosin, of lungs, liver, and kidneys from all animals.
28-Day Repeat Dose Inhalation Toxicity Study
In this study, five groups of 10 male and 10 female rats were exposed to vapors of HFC 245fa, whole-body, 6 h/day for 28 consecutive days. The exposure levels were 0 (control), 500, 2000, 10,000 and 50,000 ppm. Additionally, two groups of five male and five female rats received concurrent exposure to 0 and 50,000 ppm for 28 days and then were held for a 2-week postexposure observation period.
The test atmospheres were generated as described for the 14-day study except that the test compound was vaporized in a copper coil warmed to 50°C. The test atmospheres were monitored by gc at least at hourly intervals. The animals were exposed in stainless steel and glass chambers, each with an internal volume of 0.75 m 3 . Temperature (23.2-24.7°C) and humidity (33-46 %) were monitored and controlled during the exposures. The air flow through the chambers was approximately 150 liters per minute. Animals were observed daily both in home cages and during exposure. Detailed clinical observations, body weight measurements, and food consumption determinations were conducted weekly.
Blood and urine samples were collected during the final week of exposure for the main study population and at the end of the postexposure observation period for the remaining rats. All rats received an ophthalmic examination pre-exposure and all control and high exposure level rats received a similar examination prior to sacrifice. Hematologic examinations were conducted using a Bayer-Technician H*IE analyzer (Bayer Diagnostics, UK; reagents, Nycomed, UK). The following parameters were evaluated: packed cell volume, hemoglobin, red cell count, mean corpuscular hemoglobin concentration, mean corpuscular volume, total white cell count and differential count, platelet, Thrombotest (Baxter Healthcare, UK) and reticulocyte count. In addition, the same clinical chemistry parameters were evaluated as described for the 14-day exposure study. Urinalysis consisted of volume, pH, specific gravity, protein, reducing substances, glucose, ketone, bile pigments, urobilinogen, and haem pigments. In addition, urinary and blood fluoride levels were measured. At sacrifice, organ weight measurements were conducted on the adrenals, brain, epididymides, heart, kidneys, liver, lungs, ovaries, spleen, and testes. Liver peroxisome activity was determined as described for the 14-day study. A complete set of tissues was collected from all animals . The eyes were preserved in Davidson's fixative, the testes and epididymides in Bouin's fluid, and the remaining tissues in 10% formalin. Tissues from all control and high exposure group animals were examined, as well as target organs from all other treatment groups.
13-Week Repeat Dose Inhalation Toxicity Study
For this study, groups of 10 male and 10 female rats were exposed, whole body, to vapors of HFC 245fa for 6 h/day, 5 days per week for 13 weeks.
During the first 4 weeks of the study, the exposures were conducted concurrently with the 28-day study. During other portions, exposures were concurrent with the rat teratology study. This procedure was utilized to conserve the test material. The 0.75-m 3 exposure chambers were operated at an air flow of 150 l/min. Exposure levels were generated and measured as described for the 28-day study. Body weight, food consumption, and clinical assessments were conducted weekly. Hematology, clinical chemistry, urinalysis, and histopathology were the same as described in the 28-day study.
Statistical Analysis
Where appropriate, all groups were compared to the respective control populations. The statistical methods have been described previously (Brock et al., 1995; Rusch et al., 1995) .
Quantitative data were analyzed by Bartlett's test for homogeneity. If the data were heterogeneic, a logarithmithic transformation was performed to see if a more stable variance could be obtained. Data without significant heterogeneity were analyzed by one-way analysis of variance, and Williams test (Williams 1971 (Williams , 1972 for dose response. The Kruskal-Wallis analysis (Hollander and Wolf, 1973) was used as a covariate in the analysis of covariance.
RESULTS
Genetic Assays
HFC 245fa was not active in either of two Ames assays that were run as vapor phase studies employing airborne concentrations up to 40% v/v or 100% v/v. The studies were conducted using five strains of Salmonella typhimurium (TA 98, 100, 1538, initial study only, 1535, and 1537) and Escherichia coli (WP2 uvrA) with and without S-9 metabolic activation.
The mutagenic potential of pentafluoropropane was also evaluated using the in vitro cytogenetics study with cultured human lymphocytes, as can be seen from the information in Table 1 . In this assay, weak evidence of clastogenic activity was seen in the absence of S-9 with 24-h exposures to levels of 30 and 40%, but not with 24-h exposures at 10 or 20%, nor with 6-h exposures to any concentration. No evidence of clastogenic activity was seen in cultures with S-9. In all cases where evidence for clastogenicity was seen, there was also a reduction in mean mytotic index suggestive of cytotoxicity.
The potential for a 4-h exposure to 100,000 ppm of pentafluoropropane to cause chromosomal or other damage leading to the formation of micronuclei was evaluated in polychromatic erythrocytes from mice. There was no evidence of induced chromosomal or other damage leading to micronucleus formation in polychromatic erythrocytes of treated mice evaluated 24 and 48 h after exposure.
Acute Toxicity
The acute dermal toxicity was evaluated using a group of five male and five female New Zealand white rabbits. A dose of 2 ml/kg was applied to the back of each rabbit and was covered by an occlusive dressing for 24 h. There were no adverse reactions to this treatment. Gross necropsy and organ weights were unremarkable. There were also no signs of local irritation. Given that HFC 245fa is a volatile liquid, most if not all probably evaporated through the occlusive dressing prior to the end of the 24-h contact period.
Due to limitations in the quantity of the test compound, the initial inhalation toxicity study was conducted as a screen evaluation. In this study a group of five male and five female mice given a single 4-h snout-only exposure to a level of 101,300 (Ϯ 12,900) ppm v/v of pentafluoropropane. A sham air-exposed control group was also included. Both groups were held for a 14-day observation period. There were no effects on body weight observations, and gross necropsy and organ weights were normal. During the exposures, the treated mice all showed signs of reduced activity. This sign abated almost immediately upon cessation of the exposure. Following the study in mice, three 4-h inhalation exposures, two whole body and one snout only, were conducted with rats. Each exposure used a group of five male and five female Sprague Dawley CD rats. The exposures were for 4 h and were followed with a 14-day postexposure observation period. Sham air-exposed control groups were included in both studies. In the snout-only exposure, a single group of rats was exposed to a level of 116,000 (Ϯ 5200) ppm v/v. In the whole-body exposure, two groups of rats received 4-h exposures to levels of 143,000 (Ϯ 1800) or 203,000 (Ϯ 1000) ppm v/v/, respectively. There was no mortality following any exposure. There were no effects on body weight. Food consumption was slightly reduced on the day following exposure in the groups exposed to 143,000 and 203,000 ppm but rebounded on the following day. Water consumption was unaffected. Signs of central nervous system depression such as irregular respiration, restless behavior, intermittent muscular contractions, abnormal posture, and reduced response to external stimuli were seen during the exposures and rapidly disappeared at the end of the exposures. These signs were more pronounced in the highest exposure level group but were seen to some degree at all levels. No significant clinical signs were seen during the 14-day observation period. Overall, exposure of rats to levels as high as 203,000 ppm resulted in minimal, reversible clinical signs of central nervous system depression. No other signs of toxicity were noted.
Cardiac Sensitization to Epinephrine 2
A group of six dogs was assigned to the study. One dog could not be trained to accept the procedure, and although it was exposed at all four levels, no useful information was collected. A second dog was exposed at 73,000 ppm. Almost immediately he developed a fatal ventricular fibrillation. Due to the rapidity and severity of the response, no additional animals were exposed at this level. Exposure at 44,000 ppm resulted in one animal (1371) developing a transient ventricular fibrillation. One other dog (1375) although not showing a cardiac response, did show signs of muscle rigidity and restlessness. Although at 54,100 ppm no animals showed any indication of developing an arrhythmia, all showed a clinical response to the exposures, typically restlessness and muscle rigidity with a loss of ability to support their own weight. Dog 1371 was not exposed at this level as it had given a positive response at 44,000 ppm.
Exposures at 34,100 ppm did not result in either cardiac arrhythmias or clinical responses to the exposures. Based on these findings, exposure to 44,000 ppm of pentafluoropropane represented the threshold for cardiac sensitization and exposure at 34,100 represented the NOEL for cardiac sensitization. The results from this study are summarized in Table 2 .
Developmental Toxicity Studies
Initially, a pilot study was conducted to help define appropriate exposure levels for the main study. In this pilot study, groups of 12 time-mated female rats were exposed to vapors of pentafluoropropane at levels of 0 (control), 500, 2000, 10,000 or 50,000 ppm 6 h/day from days 7-21 of gestation. At 50,000 ppm there was a reduction in body weight gain in the dams between days 9 and 13. There were no obvious effects on litter parameters at this level. There were no observable effects on dams, litter parameters, or macroscopic external fetal structure at the lower levels. It was concluded that 50,000 ppm would be an appropriate high exposure level for the main teratology study.
The main teratology study utilized exposure levels of 0 (control), 503 Ϯ 37, 2070 Ϯ 120, 10,350 Ϯ 360, and 51,900 Ϯ 2400 ppm v/v, respectively. Each group consisted of 25 timemated females. Exposures were conducted for 6 h per day on days 6 -19 of gestation. At 50,000 ppm, reductions in percent body weight change and food consumption were noted for the period from day 6 to day 12, and a reduction in food consumption was noted for the period from day 12 to day 19. These data are summarized in Tables 3 and 4 , respectively. No effects were seen in the dams at 500 and 2000 ppm.
With the exception of uterine, litter, and fetal weights, no significant effects were seen on any fetal parameters at any exposure levels (Table 5 ). Pup weights, and thus litter and uterine weights, were reduced in the 50,000 ppm exposure level group compared with controls. The incidence of malformations, skeletal and visceral anomalies, and skeletal variants was comparable in all groups. The incidence of malformations is presented in Table 6 .
In conclusion, 50,000 ppm was considered to be the NOEL for fetal abnormalities, 10,000 ppm was the NOEL for fetal weight and 2000 ppm was the NOEL for maternal body weights.
Inhalation Toxicity Studies
A 2-week pilot inhalation toxicity study was conducted to provide information for setting the exposure levels for the subsequent 28-day and 13-week inhalation toxicity studies. In this study, four groups of five male and five female rats were exposed snout only to vapors of pentafluoropropane at levels of 0 (control), 5000, 15,000, and 50,000 ppm, respectively. The exposures were 6 h per day for 14 consecutive days. The mean exposure levels for this study were 0 (control), 5050 Ϯ 110, 15,200 Ϯ 280 and 50,400 Ϯ 840 ppm. There was no mortality. Body weights were unaffected. There were no macroscopic or microscopic effects, and organ weights in treated rats were similar to control values. Increases were seen in blood urea nitrogen levels (all groups), GPT (mid and high exposure levels), and GOT (all groups). In addition, a decrease in cholesterol levels was seen in the females at all levels. These findings are presented in Table 7 . Based on these results, exposure levels of 500, 2000, 10,000 and 50,000 ppm were selected for the subsequent 28-day and 13-week inhalation toxicity studies.
Following completion of the pilot 14-day inhalation toxicity study, two comprehensive inhalation studies were conducted. The studies were run concurrently in the same inhalation chambers and used exposure levels of 500, 2000, 10,000, and 50,000 ppm. All exposures were 6 h per day.
In the first study, groups of 10 male and 10 female rats were exposed for 28 consecutive days and then sacrificed. A second group of five male and five female rats was also exposed for the same 28 consecutive days to air or the high level of HFC 245fa and then held without treatment for a 2-week period prior to sacrifice. The mean exposure levels for this study were 0 (control), 516 Ϯ 236, 2000 Ϯ 430, 10,100 Ϯ 790 and 49,600 Ϯ 3520 ppm v/v, respectively.
There were no biologically significant differences in body weights or organ weights in treated animals compared to controls. Two high exposure level females were found dead during the study. It is unlikely that these deaths were related to the treatment for several reasons: 1) all other animals in this and the concurrent 13-week study survived the full exposure regime without noticeable adverse effects of any kind; 2) these two animals showed no signs of treatment-related effects prior to being found dead; 3) the animals died during a nonexposure period and the test substance is expected to be rapidly cleared from the body; 4) microscopic examination of tissues from these two animals did not reveal anything suggestive of a treatment-related lesion; and 5) it is further unlikely that these deaths could have resulted from cardiac sensitization of the heart to adrenaline as this response occurs only during exposure and the deaths occurred during a nonexposure period. In addition, the dog, especially when given an injection of epinephrine, is a very sensitive model, more sensitive than the rat, yet the dog responses at this level were minimal. Urine volume was increased in the 10,000 and 50,000 ppm exposure level groups together with a decrease in specific gravity and urinary protein. Possibly related to the increased urine volume and dehydration, increases were seen in packed cell volume (PCV), hemoglobin (Hgb), and red blood cell counts (RBC). These changes were seen predominately in the 10,000 and 50,000 ppm male and female exposure level groups, although a few changes were also seen in the 2000 ppm female exposure level group. A few other differences were seen in the 50,000 ppm group, including increases in reticulocytes in males and decreases in females, decreases in white blood cell counts in females, and a decrease in lucocytes in males and females. All showed recovery in the animals held for 2 weeks post final exposure. Serum chemistry analyses indicated increase in blood urea nitrogen (BUN), alkaline phosphatase (AP, females only), glutamic-pyruvic transaminase (GPT), glutamic-oxaloacetic transaminase (GOT) levels and creatine phosphokinase (CPK), also predominately in the 10,000 and 50,000 ppm exposure level groups. BUN levels in female rats were also increased at 500 and 2000 ppm. Additionally, there was a non-dose-related decrease in cholesterol levels in female rats at all treatment levels. This was not seen in male rats. All parameters showed marked improvement in the rats sacrificed 2 weeks following the final exposure. Significant clinical findings from the animals sacrificed at 4 weeks are shown in Table 8 . Increases were also seen in urinary fluoride levels in rats in the 2000, 10,000 and 50,000 ppm exposure levels groups (Table 9 ). Urinary fluoride levels were at background levels at the end of the 2-week postexposure period. There were no microscopic changes suggestive of a treatment-related effect. A summary of microscopic findings for the heart, kidney, and liver is presented in Table 10, Table  11, and Table 12 .
During the first 4 weeks, exposures for the 13-week study were run concurrently with the 28-day study and in the same chambers. Exposures for the 13-week study were for 6 h per day, 5 days per week. As the animals in the 28-day study received exposures 7 days per week, they were exposed alone for 2 days and with the animals from the 13-week study for 5 days per week. For the 13-week study, groups of 10 male and 10 female rats were used. The mean exposure levels for this study were 0 (control), 508 Ϯ 61, 2040 Ϯ 180, 10,150 Ϯ 570 and 50,600 Ϯ 3000 ppm.
No animals died during the exposure phase of the study. One high exposure level male rat died under anesthesia during week 13 blood collection. There were no clinical signs observed that appeared to be related to the treatment with HFC 245fa. There were no effects on body weight, body weight gain, or food consumption. Urinary fluoride levels were significantly increased at all exposure levels, as shown in Table 13 . Serum fluoride levels were below the level of detection in all groups. Urine volumes were increased primarily in the 10,000 and 50,000 ppm exposure level groups. Urine volumes for female rats in the 500 and 2000 ppm exposure level groups were also larger than for the female controls. However, as the control female urine volume was lower than expected, this observation may have been more a reflection of this lower control value. Although urinary protein concentrations in female rats were decreased generally in an exposure-related manner, mean total urinary protein did not show a similar effect, and the decrease appears to be related to the increase in urine volume and resultant dilution. In the male rats, a similar effect was seen at the highest two exposure levels; however, it did not follow an exposure-related pattern (Table 14) . Several hematologic parameters showed small increases in the 10,000 and 50,000 ppm exposure level groups. These appear to be related to slight dehydration resulting from increased urine output. PCV and cell count values are shown in Table 14 . The white cell counts were also increased in male rats, but the pattern did not indicate that this was related to the exposure (Table 14) . This was not seen in the female rats. BUN levels were elevated solely for the female rats in the 50,000 ppm exposure level group. A similar increase was seen in alkaline phosphate activity for this group. GPT and creatine phosphakinase were increased in both male and female rats in the 10,000 and 50,000 ppm exposure level groups. GPT and CPK were not elevated in female rats in the 10,000 ppm exposure level group. Although a few other parameters showed differences from control values, none presented a pattern indicative of a response to treatment.
Gross necropsy examination did not reveal anything suggestive of a treatment-related response. Analysis of organ weight data showed an increase in lung (115% of control) and spleen (120% of control) weights in the male rats in the 50,000 ppm exposure level group. As no trend was seen in the males in the lower exposure level groups and no changes at all were seen in the treated female rats, these observations were not considered toxicologically significant. All organs, except for the heart, were considered normal. In the heart, both focal and diffuse myocarditis were noted, characterized by foci or areas of inflammatory cell infiltration and degenerate myocardial fibers. Focal myocarditis, seen in controls and all treatment groups, was judged to be spontaneous in origin. Diffuse myocarditis was seen in the 10,000 and 50,000 ppm exposure level groups and in one animal in the 2,000 ppm exposure level group. The effects seen at 10,000 and 50,000 ppm are believed to be related to the treatment. The single incidence of diffuse myocarditis seen in one female at 2,000 ppm was described as trace and was not statistically significant, but may represent a threshold for this effect. These data are summarized in Tables 10, 11 , and 12 along with comparable data from the 28-day study.
DISCUSSION
As is typical for hydrofluorocarbons (Collins et al., 1995; Kawano et al., 1995; Hudson-Walker, et al. 1993) , HFC 245fa was not active in the Ames assay nor the mouse micronucleus assay. Although it did show an increase in aberrations in the cytogenetics study, this was only in the absence of S-9, and only in experiments that involved exposure atmospheres of 30% or more and with a contact time of 24 h. No mutagenic activity was seen in the presence of S-9 nor in studies where the cultures were exposed for 6 h, even with concentrations as high as 70% in the air. Overall, the weight of evidence would imply that pentafluoropropane is not an active mutagen.
Again, as is typical for hydrofluorocarbons, pentafluoropropane was not a dermal irritant or toxin. It also has a low level of acute toxicity by the inhalation route. In a snout-only exposure with mice, no lethality was seen even with exposure levels over 100,000 ppm for 4 h. In rats, 4-h whole body exposures to levels as high as 203,000 ppm did not cause mortality. Although some signs of mild central nervous system depression were seen with exposures at 143,000 and 203,000 ppm, these were only seen during the exposure, with the animals showing recovery within 30 min of the end of the exposure period. These findings indicate that pentafluoropropane is not acutely toxic by inhalation and that even high level exposures do not result in marked signs of toxicity. The cardiac sensitization study was designed to develop the maximum amount of data using the smallest number of dogs. Therefore, when dog 1351 died as a consequence of epinephrine administration during exposure to 73,000 ppm of pentafluoropropane, the remaining exposures at this level were cancelled. Instead, dogs were exposed to 54,100, 44,000 and 34,100 ppm. One of four dogs showed a response at 44,000 ppm and none of three or four, respectively, exposed showed responses at 54,100 or 34,100 ppm. Based on these findings, 44,000 ppm is considered to be the LOEL for cardiac sensitization and 34,100 ppm was taken as the NOEL. This finding is typical of hydrofluorocarbons such as tetrafluoroethane, which 
has a threshold of 75,000 ppm and a NOEL of 50,000 ppm (ECETOC, 1995a) . It is also higher than that seen with many chlorofluorocarbons such as CFC-11 and CFC-113, which both have thresholds for response at 2500 ppm in studies with epinephrine (Reinhardt et al., 1973) ; or hydrochlorofluorocarbons such as dichlorofluoroethane, which has a threshold of 10,000 ppm; and dichlorotrifluoroethane, which has a threshold of 20,000 ppm (NRC, 1996) . These findings are particularly noteworthy in that most fatalities following overexposures to chlorofluorocarbons are the result of ventricular fibrillation following arrhythmias. This assay, because it utilizes injections of adrenaline, is believed to be highly sensitive (NRC, 1996; Reinhardt et al., 1971) , and substances showing an effect only above 10,000 ppm in this assay would represent a minimal risk. A developmental toxicity study was conducted using rats. In this study, daily 6-h exposures were conducted at levels of 500, 2000, 10,000, and 50,000 ppm from day 6 to day 19 of gestation. There was no increase in frequency of skeletal or visceral malformation. A decrease in body weight gain was seen in the dams exposed to 50,000 ppm (19%) and to a lesser degree in the dams exposed to 10,000 ppm (6%). In the high level exposure group, this resulted in a reduction in uterine, litter, and fetal weights, all interrelated. No other effects were seen. In the three inhalation toxicity studies, consistent elevations were seen in BUN levels and several serum liver enzyme activities. Additionally, there were increases in urine volume and urinary fluoride levels. Although fluoride ion is known to be a renal toxin (Rosenholtz et al., 1963) there was no histopathologic evidence for renal toxicity in these studies. As the elevations in BUN were always less than double control values, it is probable that they resulted from either a dehydration of the animal caused by fluoride ion-induced diuresis or other subtoxic response to the fluoride ion. Increases in serum liver enzyme activities again were unaccompanied by histopathologic changes in the liver. They did tend to follow an exposurerelated pattern, with exposures at and below 2000 ppm being NOELs. Although the GOT levels showed a greater percentage increase at 13 weeks (Table 14) compared to 4 weeks (Table  8) , AP and GPT levels did not show marked differences at these two time intervals. It is therefore unlikely that we are seeing an effect that, in a longer term study, would progress to marked hepatoxicity. The findings of myocarditis are not typical for studies involving hydrofluorocarbons (Collins et al., 1995; ECETOC, 1995a, b; Kawano et al., 1995) . They have been reported in some studies involving halogenated hydrocarbons such as 1,2-difluoroethane (Keller et al., 1996) and 1,1,1,3-tetrachloropropane (Kolesar et al., 1995) . Although the material used in this study was of high purity, the exposure levels were also high; the possibility of a chlorinated impurity being responsible for this finding, though unlikely, cannot be completely dismissed. Myocarditis was described as slight to mild in the 10,000 ppm exposure level group. When one considers that body weight gain and clinical observations appeared normal, this finding did not appear to have compromised the overall health status of the rats. However, one cannot be certain if these effects could have progressed if the exposure had continued past 3 months. It does appear that 2000 ppm represents a no-effect level or at most the threshold for this effect.
28-Day
Considering all of these studies, HFC 245fa appears to show only minimal toxicity. Exposures below 5000 ppm have not shown clear signs of toxicity, and effects seen up to 50,000 ppm have been mild.
